OPEN MEDICINE, vol.16, no.1, pp.192-197, 2021 (Journal Indexed in SCI)
Background - Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.